ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD 251.08
+2.15 (0.86%)
Jan 9, 2026, 4:49 PM GMT
ResMed Market Cap
ResMed has a market cap or net worth of 27.43 billion as of January 9, 2026. Its market cap has increased by 1.13% in one year.
Market Cap
27.43B
Enterprise Value
27.03B
Revenue
3.91B
Ranking
n/a
PE Ratio
25.64
Stock Price
251.08
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 24.33M to 27.43B, an increase of 112,636.75%. That is a compound annual growth rate of 25.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 27.43B | 5.17% |
| Dec 31, 2025 | 26.08B | -2.76% |
| Dec 31, 2024 | 26.82B | 35.04% |
| Dec 29, 2023 | 19.86B | -21.72% |
| Dec 30, 2022 | 25.37B | -9.78% |
| Dec 31, 2021 | 28.12B | 24.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 220.60B |
| GSK plc | 76.29B |
| Haleon | 33.27B |
| Smith & Nephew | 10.66B |
| Convatec Group | 4.75B |
| Hikma Pharmaceuticals | 3.47B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.76B |